Chitosan-maleic acid conjugate as potential excipient candidate for oral drug delivery?

Future Med Chem. 2023 Feb;15(3):241-253. doi: 10.4155/fmc-2022-0258. Epub 2023 Mar 6.

Abstract

Aim: To develop and evaluate chitosan-maleic acid conjugate. Methods: Maleic anhydride was attached to chitosan backbone via amide bond formation resulting in chitosan-maleic acid. After characterization of the product via 1H nuclear magnetic resonance, attenuated total reflectance-Fourier transform IR spectroscopy and 2,4,6-trinitrobenzenesulfonic acid assay, examination of mucoadhesion assessment was carried out. Results: The conjugate presented 44.91% modification and no toxicity could be observed after 1 day of incubation. Mucoadhesive properties exhibited 40.97-fold, 13.31-fold and 9.07-fold increase in elastic modulus, dynamic viscosity and viscous modulus, respectively. Moreover, detachment time was increased in 44.44-fold. Conclusion: Chitosan-maleic acid demonstrated enhanced in mucoadhesive properties resulting in biocompatibility. Therefore, potent candidates as polymeric excipients for oral drug delivery could be developed over corresponding chitosan.

Keywords: chitosan; cytotoxicity; maleic acid; mucoadhesion; rotating cylinder; texture analyzer.

MeSH terms

  • Chitosan* / chemistry
  • Drug Delivery Systems / methods
  • Excipients / chemistry
  • Sulfhydryl Compounds / chemistry

Substances

  • Chitosan
  • Excipients
  • maleic acid
  • Sulfhydryl Compounds